Assistant Professor, Neurology, Mayo Medical School
Neurology
Dr. Daniel H. Lachance, MD
|
|
Give Review
Daniel Lachance practices Neurology. He researched medicine at Geisel School of Medicine at Dartmouth. Geisel School of Medicine at Dartmouth is ranked 37 in research and 29 in primary care medicine Doctor Daniel H. Lachance, MD is a published doctor and has 49 publications published. The lastest was: 'In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency.' Dr. Daniel H. Lachance is registered with Medicare and accepts Medicare payments.
Publications
- History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC).
- Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study.
- A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.
- Telomere maintenance and the etiology of adult glioma.
- Germline mutations in shelterin complex genes are associated with familial glioma.
- Socioeconomic status and glioblastoma risk: a population-based analysis.
- Pleomorphic XanthoAstrocytoma: Natural History and Long-term Follow-up.
- Exploring primary Brain tumor patient and caregiver needs and preferences in brief educational and support opportunities.
- Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral Neuropathy.
- Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.
- Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
- Stroke-Like Migraine Attacks after Radiation Therapy (SMART) Syndrome Is Not Always Completely Reversible: A Case Series.
- Striational antibodies in a paraneoplastic context.
- Autoimmune chorea in adults.
- Analysis of 60 reported glioma risk SNPs replicates published GWAS findings but fails to replicate associations from published candidate-gene studies.
- Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal Gliomas regardless of grade or histology.
- Gliomatosis cerebri: clinical characteristics, management, and outcomes.
- A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and Astrocytomas with IDH1 or IDH2 mutation.
- Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group tr...
- Psychiatric manifestations of voltage-gated potassium-channel complex autoimmunity.
- Associations of High-Grade Glioma With Glioma Risk Alleles and Histories of Allergy and Smoking.
- Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1.
- Neuronal voltage-gated potassium channel complex autoimmunity in children.
- Distinct germ line polymorphisms underlie glioma morphologic heterogeneity.
- Seizures in patients with glioma treated with phenytoin and levetiracetam.
- Positron emission tomography-computed tomography in paraneoplastic neurologic disorders: Systematic analysis and review.
- Epidemiologic investigation of immune-mediated polyradiculoneuropathy among abattoir workers exposed to porcine Brain.
- Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
- Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments.
- Frequency of seronegativity in adult-acquired generalized myasthenia gravis.
- Creutzfeldt-Jakob Disease with focal electroencephalographic and magnetic resonance imaging findings.
- Multiple sclerosis, Brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience.
- An unusual presentation of rheumatoid meningitis.
- Oculobulbar involvement is typical with Lambert-Eaton myasthenic syndrome.
- Targeted sequencing in chromosome 17q linkage region identifies familial glioma candidates in the gliogene consortium.
- A germline variant in the TP53 polyadenylation signal confers Cancer susceptibility.
- An outbreak of neurological autoimmunity with polyradiculoNeuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study.
- Spinal intradural extraosseous Ewing''s sarcoma.
- A new herbarium-based method for reconstructing the phenology of plant species across large areas.
- Opsoclonus as a suspected paraneoplastic syndrome of endometrial Cancer.
- Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: intravitreal triamcinolone acetonide therapy of four eyes.
- Paraneoplastic brachial plexopathy in a patient with Hodgkin's Disease.
- Primary leptomeningeal lymphoma: report of 9 cases, diagnosis with immunocytochemical analysis, and review of the literature.
- SMART: stroke-like Migraine attacks after radiation therapy.
- Acute Peripheral arterial occlusion: electrophysiologic study of 32 cases.
- Dose escalation trial of cyclophosphamide with Sargramostim in the treatment of central Nervous system (CNS) neoplasms.
- Cyclophosphamide in combination with sargramostim for treatment of recurrent Medulloblastoma.
- In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency.
Schools
Dartmouth Medical School
Mayo Grad School MedMayo Fndn
Rhode Island Hospital Lifespan
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Bell's Palsy
- Brachial Plexus Palsy
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
Brown University -
Geisel School of Medicine at Dartmouth
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1750369427 | |
| NPPES Provider LastName | LACHANCE | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Neurology | |
| Total Claim Count | 140.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750369427 |
| Last Name Of The Provider | LACHANCE |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Keith A. Johnson, MD |
|
|
Dr. Nathan P. Young, DO |
|
|
Dr. Christopher H. Hunt, MD |
|
|
Dr. Kogulavadanan Arumaithurai, MD
 This Doctor is OpenDoctor Recommended.
|